Share
Save

ILSI Europe at FENS – 13th European Nutrition Conference

Dublin, Ireland
15/10/2019 – 18/10/2019

Presentations from the event are available*, just click on the links in the titles below.

*Upon acceptance from the speakers


Background
ILSI Europe sessions are jointly organised by the Food Safety and Nutrition Task Forces:
Consumer Behaviour Determinants (CBD TF)
Dietary Carbohydrates (DC TF)
Dietary Intake and Exposure (DIET TF)
Early-Life Nutrition and Long-Term Health (ENLH TF)
Health Benefits Assessment of Foods (HBA TF)
Nutrient Intake Optimisation (NO TF)
Nutrition and Mental Performance (MP TF)
Obesity and Diabetes (OD TF)
Qualitative Fat Intake (QFI TF)

Booth
ILSI Europe had a booth in the Exhibitor area. Meet us booth #6.

Session 1: From early-life events to the ageing brain: Impact of nutrition on health determinants
13:30-15:00 Wednesday, 16th October, 2019 Liffey Hall 1 (Level 1)

The aim of this session was to provide an overview of ILSI Europe’s activities related to the impact of nutrition on health during the lifespan. Environmental and nutritional factors may impact long-term effects on brain and behaviour. Hence, there is probably a key role for nutrition in influencing health and well-being already early in life, also through microbiota-mediated effects. The first talk provided insights into the role of gut microbiota in programming health and disease during the early stages of life. Since microbial imbalance plays a role in sub-optimal human metabolism, and is linked to impaired immune and brain functions associated with ageing, the second talk highlighted many dietary components that may prevent, or reduce the severity of age-related functional decline and the onset of unfavourable health. The session ended with an overview of the impact of nutrition on the ageing brain with a focus on whether diet and nutrients have efficacy in individuals affected by dementia and other neurodegenerative conditions.

Speakers
Role of bacterial transfer via the placenta in the colonisation of the infant gut (presentation not available)
Christine Edwards, University of Glasgow, Glasgow, United Kingdom
Health Relevance of the Modification of Low Grade Inflammation in Ageing (Inflammageing) and the Role of Nutrition (presentation not available)
Stefano Salvioli, University of Bologna, Bologna, Italy
Nutrition for the Ageing Brain
David Vauzour, University of East Anglia, Norwich, United Kingdom

Session 2: New methodologies for food intake and dietary exposure assessment
5:00-16:30 Wednesday, 16th October, 2019 – Wicklow Hall 2B (Level 2)

The aim of this session was to highlight ILSI Europe’s activities in establishing the links between various components of the food, their optimal intake levels and public health. The first talk evaluated the potential for incorporating data on Occurrence and Consumer Loyalty into dietary exposure models. The second speaker reviewed the latest improvements in dietary intake assessment methodologies. The final talk provided an overview of the latest advancements in the identification and validation of markers for glycaemia for the non-diabetic population.

Speakers
The potential for incorporating data on occurrence and consumer loyalty into dietary exposure models
John Paul Gosling, University of Leeds, Leeds, United Kingdom
Evaluation of new methods for dietary intake assessment (presentation not available)
Janet Cade, University of Leeds, Leeds, United Kingdom
Applicability of markers of sustained glycaemic exposures for use in the population without diabetes (presentation not available)
Edith Feskens, Division of Human Nutrition, Wageningen University, Wageningen, Netherlands

Session 3: An update on ILSI’s Europe activities on Glycaemic Exposure: from the population without diabetes to Gestational Diabetes Mellitus
10:45-12:15 Wednesday, 16th October, 2019 – EcoCem (Level 2)

The aim of this session highlighted ILSI Europe’s on Glycaemic Exposure. The first talk focused on the health Impact of Reducing Post-Prandial Glycaemia via drug or diet intervention. The second talk reviewed the efficacy of type 2 diabetes markers in evaluating the effectiveness of food intervention in non-diabetic population. Finally, we provided insights into how food intervention could influence Gestational Diabetes Mellitus.

Speakers
Gestational Diabetes Mellitus and Diet: Impact of Modified Dietary Interventions on Maternal Glucose Control and Neonatal Birth Weight  (presentation not available)
Rosa Corcoy, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
Quantifying the Health Impact of Reduced Post-Prandial Glycaemia
Denise Robertson, University of Surrey, Surrey, United Kingdom
Alternative Markers for Insulin Sensitivity and Secretion
Ian Macdonald, University of Nottingham, Nottingham, United Kingdom

Session 4: An Update on the Beneficial Health Impact of Specific Dietary Fatty Acids
14:45-16:15 Thursday, 17th October, 2019 – Wicklow Hall 1 (Level 2)

The aim of this session was to highlight ILSI Europe’s activities on the beneficial impact of specific dietary fatty acids on human health. The talks provided an overview of the health impact of diets rich in Omega-3 and Omega -6 (talk 1), specific saturated fatty acids (talk 2) or ω -3 and ω -6 (talk 3).

Speakers
A systematic review of the effects of increasing arachidonic acid intake on pufa status, metabolism and health-related outcomes in humans
Philip Calder, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
ω -3 and ω -6 PUFA intakes, ratios and potential health effects (presentation not available)
Ronald Mensink, University of Maastricht, Maastricht, Netherlands
Update on Health Effects of Different Dietary Saturated Fatty Acids
Peter Joris, University of Maastricht, Maastricht, Netherlands

Session 5: Understanding Consumer Choice Drivers to Achieve Sustainable Food and Nutrition Security
16:45-18:15 Thursday, 17th October, 2019 – Wicklow Hall 1 (Level 2)

Unhealthy food choices and related behaviours are currently driving increased rates of obesity in Europe, with concomitant increases in the incidence of non-communicable diseases. Approaches such as Nudging, the Nutri and PEF-score, policy instruments and personalised nutrition are being widely adopted as a measure to encourage healthier consumer food choices, although there is mixed evidence to support its use as a behavioural intervention, in particular in terms of long term dietary changes. In addition, various theoretical approaches and methodological perspectives have been retrospectively aggregated under the “nudging” umbrella, in the absence of a formalised definition or theoretical perspective on what nudging actually represents. The proposed session aimed to discuss the existing evidence base regarding the short and long term impacts of nudging, and to identify gaps in knowledge where these exist.

Speakers
Evidence-based policy instruments to promote climate-friendly and healthy diets in Europe
Xavier Irz, Natural Resources Institute Finland (Luke), Helsinki, Finland
Personalised Nutrition opportunity or threat to European food sustainability
Barbara Stewart-Knox,  University of Bradford, Bradford, United Kingdom
Towards healthy and sustainable food choices empirical evidence from the use of the nutri and PEF score
Michiel De Bauw, KU Leuven, Leuven, Belgium

Session 6: Unlocking the potential of the microbiome
10:45-12:15 Friday, 18th October, 2019 – Liffey Hall 2 (Level 1)

ILSI Europe Session ‘Unlocking the potential of the microbiome’ explores the role gut and oral microbiome play in human health and chronic diseases such as obesity and diabetes. The three talks provide insights into the impact of diet on intestinal microbiome and its metabolism as well as discuss possibilities nutritional interventions offer for shaping gut microbiome beneficially. This includes presentation of guidelines facilitating the design and conduct of human gut microbiome intervention studies relating to foods developed by ILSI Europe ‘Food health benefits assessment’ Task Force. Oral microbiota, its resilience and the impact of this to systemic health will be covered, too Gut and oral microbiota contribute significantly to mammalian biocomplexity, its health and disease. Cross-talk exists between the microbiota and host through a variety of mechanisms, not to mention the extraordinary metabolic potential, which the intestinal microbiota has. Perturbations in microbiota composition are associated with obesity, diabetes and allergies, but are also detected at the onset of several other non-pathogenic chronic diseases. Oral microbiota, too, is increasingly explored as a contributor to systemic diseases. The increasing understanding on the role of microbiota in defining health, coupled with the accessibility of this malleable population for dietary manipulation makes it an attractive target for improving human health and reducing disease.

Speakers
The Oral Microbiome, Oral Health Resilience and Systemic Health
Wim Crielaard, Academic Centre for Dentistry Amsterdam, University of Amsterdam, Amsterdam, Netherlands
How to conduct human gut microbiome intervention studies relating to nutrition (presentation not available)
Jonathan Swann, Imperial College London, London, United Kingdom
Linking microbiome and metabolomics in the context of dietary intake and health status (presentation not available)
Kieran Tuohy, Fondazione Edmund Mach, San Michele all’Adige, Italy

Contact
For more information on the sessions, please contact Dr Lucie Geurts, Scientific Project Manager.

*Upon acceptance from the speakers